1. Burley, D. M. and Glynne, A. (1985). In Burley, D. M. and Binns, T. B. (Eds.), Pharmaceutical Medicine Clinical Trials. Edward Arnold, London, pp. 70–109
2. Carter, S. K., Selawry, O. and Slavik, M. (1977). Methods of development of new anti cancer drugs. Clinical trials in cancer chemotherapy. Cancer, 40, 544–57
3. Dollery, C. T. and Davies, D. S. (1970). The conduct of initial studies in man. Br. Med. Bull., 26, 233–6
4. Hansen, H. H. (1970). Clinical experience with 1-(2-chloroethyl)3-cyclohexyl-1-nitrosourea (CCNU NSC 79037). Proc. Am. Ass. Cancer Res., 11, 43
5. Pitts, N. E. (1974). In MacMahon, F. (Ed.), Principles and Techniques of Human Research and Therapeutics, Volume II: Drug-induced Clinical Toxicity. Futura, New York, pp. 19–35